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ABSTRACT
Background: Ortho-phthalaldehyde (OPA) has recently been used as a disinfectant for various medical appa-
ratuses. OPA is not generally recognized as a potential allergen.
Case Summary: Subsequent to our recent report describing a patient presenting with OPA-induced anaphy-
laxis following laryngoscopy, we experienced two more such cases. In all three cases, the basophil histamine
release test was useful for identifying the allergen as OPA. OPA-specific IgE was successfully detected in the
serum of the patients by ELISA.
Discussion: Physicians and co-medical workers need to be aware of potential allergens to which patients
may be exposed during routine medical procedures.
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INTRODUCTION
Ortho-phthalaldehyde (OPA) is a recently developed
disinfectant.1 Although glutaraldehyde is still widely
used for disinfection of various medical apparatuses,
increasing numbers of hospitals are adopting OPA,
since this compound is not volatile and is much less
irritable to medical workers.2,3 Here we report three
cases of OPA-induced anaphylaxis after laryngo-
scopy. Our in vitro analyses clearly demonstrated
that OPA-specific IgE was present in the serum of all
three patients.
CLINICAL SUMMARY
CASE 1
The clinical course of this patient was already de-
scribed elsewhere.4 In brief, a 25-year-old woman de-
veloped an anaphylactic reaction with dyspnea, runny
nose, systemic urticaria, tachycardia and a mild de-
crease in the blood pressure following a laryngo-
scopic procedure for assessment of a vocal cord tu-
mor in August 2005. She had undergone once-a-
month checkups by laryngoscopy for the previous
five months. Two weeks after her anaphylaxis had
disappeared, skin tests and challenge tests were per-
formed for latex and local anesthetics, since they had
been used during the laryngoscopic procedure, but
no allergic reactions were observed. However, a dis-
infectant solution containing 0.55% OPA, which was
routinely used for pretreatment of the laryngoscope,
showed a positive reaction in an intracutaneous test
at a 1 : 1000 dilution. Her serum IgE level was 340
IUml.
CASE 2
In February 2006, a 36-year-old otolaryngologist de-
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Fig. 1 Results of histamine release tests using basophils from pa-
tients 1 (A), 2 (B) and 3 (C). Basophils were exposed to serial dilutions 
of the OPA-containing disinfectant and pure OPA solution (original con-
centration of OPA in both solutions: 0.55%) for 45 minutes at 37℃, and 
histamine released in the supernatant was assayed. Anti-IgE antibody 
at 14 μg/ml was used as a positive control stimulus. Data are mean val-
ues of duplicate determinations. The result for patient 1 was already 
reported.4
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veloped an anaphylactic reaction including tachycar-
dia, sneezing, runny nose and general urticaria imme-
diately after a laryngoscopic demonstration of his vo-
cal cord. Treatment with chlorpheniramine and hy-
drocortisone was effective in relieving his symptoms.
He had previously performed such laryngoscopic pro-
cedures many times. His serum IgE level was 36 IU
ml.
OPA-treated Laryngoscopy and Anaphylaxis
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Table 1 ELISA for OPA-specific IgE.
Control 4Control 3Control 2Control 1Patient 3Patient 2Patient 1
0.0080.034Exp 1
(0.008)(0.007)
0.0080.032Exp 2
(0.008)(0.012)
0.0870.2060.272Exp 3
(0.078)(0.089)(0.097)
0.0580.142Exp 4
(0.074)(0.051)
The detailed assay method was as described in the text. The results of four representative experiments are presented. Other experi-
ments using case 1 serum samples showed essentialy similar OD levels. Al experiments were performed in duplicate, and the data are 
the mean OD values measured at 450 nm. The OD values of samples loaded in wels without any HSA-precoating step prior to OPA treat-
ment are shown in parentheses.
CASE 3
In March 2006, a 58-year-old man developed an ana-
phylactic reaction immediately after laryngoscopic ex-
amination of a pharyngeal tumor. His symptoms, in-
cluding tachycardia, runny nose and general urti-
caria, improved following treatment with chlorpheni-
ramine and hydrocortisone. He had undergone sev-
eral laryngoscopic examinations during the previous
10 months. His serum IgE level was 73 IUml. A dis-
infectant solution containing OPA at a 1 : 100 dilution
gave a positive reaction at 15 minutes in an intracuta-
neous test (wheal of 14 × 10 mm and flare of 28 × 24
mm).
In all three cases, subsequent laryngoscopic exami-
nations were performed using an OPA-disinfected,
thoroughly rinsed (>15 minutes) fiberscope, and the
patients never again manifested allergic symptoms.
PATHOLOGICAL FINDINGS
IN VITRO HISTMINE RELEASE TESTS
After informed consent was obtained, venous blood
was drawn from the patients, and in vitro histamine
release tests were performed in a buffer containing
0.03% human serum albumin (HSA).5,6 All in vitro
tests and skin tests were performed after an interval
of at least two weeks after the anaphylactic episode.
Also, basophils obtained from at least one or two con-
trol subjects were included in each experiment using
the patients’ basophils. Importantly, the tests demon-
strated that both the disinfectant and pure OPA (pur-
chased from Wako Pure Chemical, Osaka, Japan)
evoked obvious release of histamine not only from
the basophils of case 1 (Fig. 1A),4 but also from the
basophils of case 2 (Fig. 1B) and case 3 (Fig. 1C). On
the other hand, the basophils from healthy control
donors did not show histamine release in response to
OPA. As already noted elsewhere, passive sensitiza-
tion experiments revealed that the serum of case 1
contained an OPA-specific, heat-sensitive component
capable of sensitizing basophils from control sub-
jects, implying the presence of OPA-specific IgE in
the serum.4
DETECTION OF SPECIFIC IGE BY ELISA
We next tried to detect the specific IgE in the pa-
tients’ serum by ELISA. The procedures were as fol-
lows: 1) coating of a 96-well polystyrene plate (Nunc,
Roskilde, Denmark) with 1% HSA in PBS at 4℃ over-
night; 2) additional coating with 0.55% OPA at 4℃ for
1 hour; 3) blocking with 1% HSA in PBS at 4℃ for 3
hours; 4) addition of 2× diluted serum samples, incu-
bated at 37℃ for 2.5 hours; 5) addition of biotin-anti-
human IgE Ab (Biosource International, Camarillo,
CA, USA) 2 μgml at 37℃ for 1 hour; 6) addition of
streptoavidin-horseradish peroxidase (Amersham Bi-
oscience Corp, Piscataway, NJ, USA) at 2 × 105 dilu-
tion at 37℃ for 30 minutes; 7) color development
with 3,3’,5,5’-tetramethylbenzidine (TMB) (Kirke-
gaard & Perry Laboratories Inc., Gaithersburg, MD,
USA) at room temperature for 15 minutes; 8) addition
of 3 N phosphate; and 9) measurement with a mi-
crotiter plate reader (Bio-Rad, Hercules, CA, USA).
The tests demonstrated the presence of OPA-specific
IgE in the sera from all three patients (Table 1), as in-
dicated by higher OD levels compared to the control
serum samples. In addition, it was possible to detect
the difference in OD values between the patients and
normal controls even if the serum samples were di-
luted up to 10-fold. Precoating of the plates with albu-
min prior to treatment with OPA was essential; when
the precoating step was omitted, detection of OPA-
specific IgE was unsuccessful. These results showed
that specific IgE in the serum of OPA-induced ana-
phylactic subjects can be detected by our ELISA sys-
tem, and that conjugation of OPA to proteins is criti-
cal for this assay method.
DISCUSSION
After we first reported a case of anaphylaxis following
an OPA-disinfected laryngoscopic procedure,4 we ex-
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perienced two additional similar patients, described
here as cases 2 and 3. Both in vitro histamine-release
tests and ELISA were useful methods for identifying
the allergen and the specific IgE. The interaction of
OPA and OPA-specific IgE antibody may be directly
involved in the pathogenesis of anaphylaxis in the pa-
tients. Presumably these patients had been sensitized
by repeated exposure to OPA remaining on the fiber-
scope.
Demonstration of the involvement of specific IgE is
often difficult for anaphylactic reactions induced by
low-molecular-weight substances. In fact, immobiliza-
tion of such small substances often destroys their an-
tigenicity, making it difficult to detect specific IgE
binding. The Prausnitz-KÜstner reaction is a tradi-
tional method for definitively demonstrating the pres-
ence of specific IgE, but it is not feasible in many situ-
ations since infection by unknown pathogens may oc-
cur. In vitro assay methods such as ELISA depend on
the binding property of the molecule.7,8 In this re-
gard, OPA (molecular weight 134.1) may be an ideal
molecule for establishing such an in vitro test system,
since this molecule binds to carrier proteins. It could
be said that OPA acts as a hapten when it induces an
anaphylactic reaction in vivo, and that in vitro hapte-
nated OPA may be antigenically potent, capable of
eliciting basophil histamine release and ELISA detec-
tion. The present cases, in addition to Sokol’s report,9
collectively suggest that repeated exposure to OPA-
disinfected equipment can sensitize some patients
due to production of specific IgE, and that OPA may
be a clinically important allergen that induces type I
allergic reactions. Thus, it is important for us to be
aware of such potential allergens to which patients
may be exposed during routine medical procedures.
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